MBTPS1 and COVID-19: Several studies have demonstrated reversal of COVID-19 complications and improved survival by modulation of SphKs and S1P-S1PR pathways (103, 105) in the recent outbreak of COVID-19 pandemic, also characterized by an inflammatory storm, hyperinflammation and septic shock (106, 107).